Loading…

Pharmaceutical & Biotech

Chinese, British Firms Jointly Invest $40 Million for Pharmaceutical Company in Tianjin

The joint venture has a registered capital of about $18 million and a total investment is expected to hit $40 million. to the company will cover pharmaceutical research ...

Released Thursday, September 27, 2007

Chinese, British Firms Jointly Invest $40 Million for Pharmaceutical Company in Tianjin

Researched by Industrial Info Resources (Sugar Land, Texas)--The Chinese pharmaceutical company Tasly (Tianjin, China) and the renowned British company Co-operative Group (Manchester, United Kingdom) have jointly invested $ 40 million to build a pharmaceutical company in Tianjin. The company, Tianjin Tasly Saint Pharmaceutical Company Limited, will be in Beichen Scientific and Technological Park.

The joint venture has a registered capital of about $18 million and a total investment is expected to hit $40 million. to the company will cover pharmaceutical research and development, troche manufacturing, and sales and marketing of manufactured products on overseas market; provision of after-sale service, technical consultation, services and training; transference of technologies relevant to its own products; merchandising, and technology export and import.

The company is expected to go into production in 2009 with an annual capacity of 200 million troches and 200 million capsules. All of its products will be sold on European market. Once built, the company will become the first international pharmaceutical company in China to have gotten approval of the GMP, FDA and MHRA.

The Tasly Group, which focuses on pharmaceuticals, was founded in May 1994. Its products cover TCM, bio-medicines, chemical medicines, health-care products and functional food. By the end of 2006, the group’s assets totaled about $1 billion.

Tasly’s product portfolio is dominated by a modern TCM system, which consists of antivirus medicine, anti-flu medicine, cardiovascular medicine, cerebrovascular medicine, anti-tumor medicine, immune system medicine and digestive medicine. The best-sellers are the Cardiotonic Pill, Nourishing Blood &Cleaning Brain Granule and Chuanxinlian Lactone Dripping Pill. Cardiotonic Pill sales exceeded about $133 million for four years in a row.

Britain’s Cooperative Group was established in 1863 and is one of the world’s largest consumer cooperatives with a turnover of more than $18.2 billion. It employs about 87,500 employees and boasts 4,500 high street outlets in the United Kingdom. Its businesses include food stores, a bank, an insurance business, funeral branches, travel agents, pharmacies and farms. Its annual sales volume exceeds $ 15 billion.

Industrial Info Resources (IIR) provides marketing communication services ranging from industrial database solutions to market forecasting, custom analytics, and specialty promotions that support high-level image campaigns.
/news/article.jsp false

Share This Article

Want More IIR News Intelligence?


Make us a Preferred Source on Google to see more of us when you search.

Add Us On Google

Please verify you are not a bot to enable forms.

What is 75 + 2?

Ask Us

Have a question for our staff?

Submit a question and one of our experts will be happy to assist you.

By submitting this form, you give Industrial Info permission to contact you by email in response to your inquiry.

A glowing computer chip is placed on a dark blue circuit board. Bright blue lines and nodes create a futuristic, technological ambiance.

Forecasts & Analytical Solutions

Where global project and asset data meets advanced analytics for smarter market sizing and forecasting.

Explore Our Solutions
Dimly lit data center with rows of towering black server racks, glowing blue lights, and a sleek, futuristic ambiance.

PECWeb Global Market Intelligence Platform

Identify opportunities, anticipate change, and execute with confidence. PECWeb connects the industrial intelligence you need, from projects and assets to operational events, all in one platform.

Discover Pecweb

Get notifications from IIR News Intelligence

Click 'Sign Up' then 'Allow'